UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

Cancer cell, 2004-10, Vol.6 (4), p.409-421

2004

Volltextzugriff (PDF)

A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial

The oncologist (Dayton, Ohio), 2017-12, Vol.22 (12), p.1427-e129

2017

Volltextzugriff (PDF)

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy

Breast cancer research and treatment, 2020-04, Vol.180 (3), p.647-655

2020

Volltextzugriff (PDF)

Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study

Clinical breast cancer, 2018-10, Vol.18 (5), p.e781-e787

2018

Volltextzugriff (PDF)

Heterozygous deficiency of delta-catenin impairs pathological angiogenesis

The Journal of experimental medicine, 2010-01, Vol.207 (1), p.77-84

2010

Volltextzugriff (PDF)

Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment

Blood, 2006-08, Vol.108 (4), p.1260-1266

2006

Volltextzugriff (PDF)

A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Clinical breast cancer, 2020-04, Vol.20 (2), p.89-97

2020

Volltextzugriff (PDF)

Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model

Magnetic resonance imaging, 2005-05, Vol.23 (4), p.519-529

2005

Volltextzugriff (PDF)

A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer

Clinical breast cancer, 2019-02, Vol.19 (1), p.1-9

2019

Volltextzugriff (PDF)

Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway

Experimental cell research, 2004-08, Vol.298 (1), p.167-177

2004

Volltextzugriff (PDF)

IκB Kinase-α Regulates Endothelial Cell Motility and Tumor Angiogenesis

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (24), p.10223-10228

2008

Volltextzugriff (PDF)

Rituximab With or Without Bevacizumab for the Treatment of Patients With Relapsed Follicular Lymphoma

Clinical lymphoma, myeloma and leukemia, 2014-08, Vol.14 (4), p.277-283

2014

Volltextzugriff (PDF)

Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: Theory, simulations, and experimental results

Magnetic resonance in medicine, 2008-02, Vol.59 (2), p.326-335

2008

Volltextzugriff (PDF)

Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T

Journal of magnetic resonance imaging, 2006-11, Vol.24 (5), p.1140-1147

2006

Volltextzugriff (PDF)

Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome

Nature medicine, 1996-01, Vol.2 (1), p.93-95

1996

Volltextzugriff (PDF)

Abstract OT2-1-08: A phase II open label study of everolimus in combination with anti-estrogen therapy in hormone receptor-positive HER2-negative advanced breast cancer

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.OT2-1-08-OT2-1-08

2015

Volltextzugriff (PDF)

Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators

Oncogene, 2010-06, Vol.29 (23), p.3335-3348

2010

Volltextzugriff (PDF)

Spontaneous immortalization of human dermal microvascular endothelial cells

World journal of stem cells, 2010-10, Vol.2 (5), p.114-120

2010

Volltextzugriff (PDF)

A phase II study with lead-in safety cohort of cabazitaxel (C) plus lapatinib (L) as therapy for HER2+ metastatic breast cancer (MBC) with intracranial metastases (mets)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS667-TPS667

2014

Volltextzugriff (PDF)

Heterozygous deficiency of δ-catenin impairs pathological angiogenesis

The Journal of experimental medicine, 2010-03, Vol.207 (3), p.669-669

2010

Volltextzugriff (PDF)

A randomized, double-blinded, placebo-controlled phase II trial of gemcitabine (gem) plus nab-paclitaxel (nab-P) plus apatorsen (A) or placebo (Pl) in patients (pts) with metastatic pancreatic cancer (mPC): The RAINIER trial

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4119-4119

2016

Volltextzugriff (PDF)

Heterozygous deficiency of δ-catenin impairs pathological angiogenesis

The Journal of experimental medicine, 2010-02, Vol.207 (2), p.443-443

2010

Volltextzugriff (PDF)

Array-Based Comparative Genomic Hybridization (aCGH) In Myelofibrosis Reveals Divergent Genetic Copy Number Alterations Among Patients With Post-Essential Thrombocythemia-Myelofibrosis/Post-Polycythemia Rubra Vera-Myelofibrosis (PET-MF and PPV-MF) and Patients With Idiopathic Myelofibrosis

Blood, 2013-11, Vol.122 (21), p.5266-5266

2013

Volltextzugriff (PDF)

Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis

American journal of physiology. Heart and circulatory physiology, 2004-07, Vol.287 (1), p.H187-H195

2004

Volltextzugriff (PDF)

Gene therapy targeting the Tie2 function ameliorates collagen‐induced arthritis and protects against bone destruction

Arthritis and rheumatism, 2005-05, Vol.52 (5), p.1585-1594

2005

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(17)
Female
(11)
Animals
(10)
Oncology
(10)
Mice
(9)
Adult
(7)
Middle Aged
(7)
Aged
(6)
Biological And Medical Sciences
(6)
Cell Biology
(6)
Cells, Cultured
(5)
Angiogenesis
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Breast Neoplasms - Drug Therapy
(4)
Breast Neoplasms - Pathology
(4)
Follow-Up Studies
(4)
Medicine, Research & Experimental
(4)
Prognosis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy

Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study

Heterozygous deficiency of delta-catenin impairs pathological angiogenesis

Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment

A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer

Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model

A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer

Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway

IκB Kinase-α Regulates Endothelial Cell Motility and Tumor Angiogenesis

Rituximab With or Without Bevacizumab for the Treatment of Patients With Relapsed Follicular Lymphoma

Incorporating the effects of transcytolemmal water exchange in a reference region model for DCE-MRI analysis: Theory, simulations, and experimental results

Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T

Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome

Abstract OT2-1-08: A phase II open label study of everolimus in combination with anti-estrogen therapy in hormone receptor-positive HER2-negative advanced breast cancer

Oncogenic mutations regulate tumor microenvironment through induction of growth factors and angiogenic mediators

Spontaneous immortalization of human dermal microvascular endothelial cells

A phase II study with lead-in safety cohort of cabazitaxel (C) plus lapatinib (L) as therapy for HER2+ metastatic breast cancer (MBC) with intracranial metastases (mets)

Heterozygous deficiency of δ-catenin impairs pathological angiogenesis

A randomized, double-blinded, placebo-controlled phase II trial of gemcitabine (gem) plus nab-paclitaxel (nab-P) plus apatorsen (A) or placebo (Pl) in patients (pts) with metastatic pancreatic cancer (mPC): The RAINIER trial

Heterozygous deficiency of δ-catenin impairs pathological angiogenesis

Array-Based Comparative Genomic Hybridization (aCGH) In Myelofibrosis Reveals Divergent Genetic Copy Number Alterations Among Patients With Post-Essential Thrombocythemia-Myelofibrosis/Post-Polycythemia Rubra Vera-Myelofibrosis (PET-MF and PPV-MF) and Patients With Idiopathic Myelofibrosis

Dual functional roles of Tie-2/angiopoietin in TNF-alpha-mediated angiogenesis

Gene therapy targeting the Tie2 function ameliorates collagen‐induced arthritis and protects against bone destruction

Suchergebnisse filtern